Home > > > > > Report Detail

Global Antidiabetics Market Insights, Forecast to 2029

Publisher Name :
Date: 11-Aug-2023
No. of pages: 109
Inquire Before Buying

Type 1 Diabetes and Type 2 Diabetes are common types of diabetes. Treatments include (1) agents that increase the amount of insulin secreted by the pancreas, (2) agents that increase the sensitivity of target organs to insulin, and (3) agents that decrease the rate at which glucose is absorbed from the gastrointestinal tract.

The global Antidiabetics market is projected to grow from US$ 61740 million in 2023 to US$ 85960 million by 2029, at a Compound Annual Growth Rate (CAGR) of 5.7% during the forecast period.

The North American antidiabetics market held the largest market revenue share in 2013. High market penetration of modern insulin products such as long-acting, rapid acting insulin analogs and DPP-4 drugs such as Januvia, Onglyza and Nesina and the presence of high healthcare expenditures, patient awareness levels, sophisticated healthcare infrastructure and reimbursement framework are the major factors contributing to its large share.

Asia Pacific on account of the rapidly improving healthcare expenditure levels, growing prevalence of type I and type II diabetes and increasing patient disposable incomes is expected to grow at the fastest rate during the forecast period.

Report Includes:

This report presents an overview of global market for Antidiabetics, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Antidiabetics, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Antidiabetics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Antidiabetics sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Antidiabetics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Antidiabetics sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Sanofi-Aventis, Takeda Pharmaceuticals, Eli Lilly, Oramed Pharmaceuticals, Boehringer Ingelheim, Merck & Co. Inc., Novo Nordisk, Bristol-Myers Squibb and Halozyme Therapeutics, etc.

By Company

Sanofi-Aventis

Takeda Pharmaceuticals

Eli Lilly

Oramed Pharmaceuticals

Boehringer Ingelheim

Merck & Co. Inc.

Novo Nordisk

Bristol-Myers Squibb

Halozyme Therapeutics

Pfizer

Segment by Type

Type 1 Diabetes

Type 2 Diabetes

Other

Segment by Application

Hospital Use

Clinic Use

Household

Other

Segment by Region

US & Canada

U.S.

Canada

China

Asia (excluding China)

Japan

South Korea

China Taiwan

Southeast Asia

India

Europe

Germany

France

U.K.

Italy

Russia

Middle East, Africa, Latin America

Brazil

Mexico

Turkey

Israel

GCC Countries

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales (consumption), revenue of Antidiabetics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 3: Detailed analysis of Antidiabetics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.

Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.

Chapter 8: China by type, by application sales and revenue for each segment.

Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.

Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antidiabetics sales, revenue, price, gross margin, and recent development, etc.

Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 14: The main points and conclusions of the report.

Global Antidiabetics Market Insights, Forecast to 2029

Table of Contents
1 Study Coverage
1.1 Antidiabetics Product Introduction
1.2 Market by Type
1.2.1 Global Antidiabetics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Type 1 Diabetes
1.2.3 Type 2 Diabetes
1.2.4 Other
1.3 Market by Application
1.3.1 Global Antidiabetics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital Use
1.3.3 Clinic Use
1.3.4 Household
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Antidiabetics Sales Estimates and Forecasts 2018-2029
2.2 Global Antidiabetics Revenue by Region
2.2.1 Global Antidiabetics Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Antidiabetics Revenue by Region (2018-2023)
2.2.3 Global Antidiabetics Revenue by Region (2024-2029)
2.2.4 Global Antidiabetics Revenue Market Share by Region (2018-2029)
2.3 Global Antidiabetics Sales Estimates and Forecasts 2018-2029
2.4 Global Antidiabetics Sales by Region
2.4.1 Global Antidiabetics Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Antidiabetics Sales by Region (2018-2023)
2.4.3 Global Antidiabetics Sales by Region (2024-2029)
2.4.4 Global Antidiabetics Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Antidiabetics Sales by Manufacturers
3.1.1 Global Antidiabetics Sales by Manufacturers (2018-2023)
3.1.2 Global Antidiabetics Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Antidiabetics in 2022
3.2 Global Antidiabetics Revenue by Manufacturers
3.2.1 Global Antidiabetics Revenue by Manufacturers (2018-2023)
3.2.2 Global Antidiabetics Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Antidiabetics Revenue in 2022
3.3 Global Key Players of Antidiabetics, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Antidiabetics Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Antidiabetics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Antidiabetics, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Antidiabetics, Product Offered and Application
3.8 Global Key Manufacturers of Antidiabetics, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Antidiabetics Sales by Type
4.1.1 Global Antidiabetics Historical Sales by Type (2018-2023)
4.1.2 Global Antidiabetics Forecasted Sales by Type (2024-2029)
4.1.3 Global Antidiabetics Sales Market Share by Type (2018-2029)
4.2 Global Antidiabetics Revenue by Type
4.2.1 Global Antidiabetics Historical Revenue by Type (2018-2023)
4.2.2 Global Antidiabetics Forecasted Revenue by Type (2024-2029)
4.2.3 Global Antidiabetics Revenue Market Share by Type (2018-2029)
4.3 Global Antidiabetics Price by Type
4.3.1 Global Antidiabetics Price by Type (2018-2023)
4.3.2 Global Antidiabetics Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Antidiabetics Sales by Application
5.1.1 Global Antidiabetics Historical Sales by Application (2018-2023)
5.1.2 Global Antidiabetics Forecasted Sales by Application (2024-2029)
5.1.3 Global Antidiabetics Sales Market Share by Application (2018-2029)
5.2 Global Antidiabetics Revenue by Application
5.2.1 Global Antidiabetics Historical Revenue by Application (2018-2023)
5.2.2 Global Antidiabetics Forecasted Revenue by Application (2024-2029)
5.2.3 Global Antidiabetics Revenue Market Share by Application (2018-2029)
5.3 Global Antidiabetics Price by Application
5.3.1 Global Antidiabetics Price by Application (2018-2023)
5.3.2 Global Antidiabetics Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Antidiabetics Market Size by Type
6.1.1 US & Canada Antidiabetics Sales by Type (2018-2029)
6.1.2 US & Canada Antidiabetics Revenue by Type (2018-2029)
6.2 US & Canada Antidiabetics Market Size by Application
6.2.1 US & Canada Antidiabetics Sales by Application (2018-2029)
6.2.2 US & Canada Antidiabetics Revenue by Application (2018-2029)
6.3 US & Canada Antidiabetics Market Size by Country
6.3.1 US & Canada Antidiabetics Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Antidiabetics Sales by Country (2018-2029)
6.3.3 US & Canada Antidiabetics Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Antidiabetics Market Size by Type
7.1.1 Europe Antidiabetics Sales by Type (2018-2029)
7.1.2 Europe Antidiabetics Revenue by Type (2018-2029)
7.2 Europe Antidiabetics Market Size by Application
7.2.1 Europe Antidiabetics Sales by Application (2018-2029)
7.2.2 Europe Antidiabetics Revenue by Application (2018-2029)
7.3 Europe Antidiabetics Market Size by Country
7.3.1 Europe Antidiabetics Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Antidiabetics Sales by Country (2018-2029)
7.3.3 Europe Antidiabetics Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Antidiabetics Market Size
8.1.1 China Antidiabetics Sales (2018-2029)
8.1.2 China Antidiabetics Revenue (2018-2029)
8.2 China Antidiabetics Market Size by Application
8.2.1 China Antidiabetics Sales by Application (2018-2029)
8.2.2 China Antidiabetics Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Antidiabetics Market Size by Type
9.1.1 Asia Antidiabetics Sales by Type (2018-2029)
9.1.2 Asia Antidiabetics Revenue by Type (2018-2029)
9.2 Asia Antidiabetics Market Size by Application
9.2.1 Asia Antidiabetics Sales by Application (2018-2029)
9.2.2 Asia Antidiabetics Revenue by Application (2018-2029)
9.3 Asia Antidiabetics Sales by Region
9.3.1 Asia Antidiabetics Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Antidiabetics Revenue by Region (2018-2029)
9.3.3 Asia Antidiabetics Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Antidiabetics Market Size by Type
10.1.1 Middle East, Africa and Latin America Antidiabetics Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Antidiabetics Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Antidiabetics Market Size by Application
10.2.1 Middle East, Africa and Latin America Antidiabetics Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Antidiabetics Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Antidiabetics Sales by Country
10.3.1 Middle East, Africa and Latin America Antidiabetics Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Antidiabetics Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Antidiabetics Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Sanofi-Aventis
11.1.1 Sanofi-Aventis Company Information
11.1.2 Sanofi-Aventis Overview
11.1.3 Sanofi-Aventis Antidiabetics Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Sanofi-Aventis Antidiabetics Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi-Aventis Recent Developments
11.2 Takeda Pharmaceuticals
11.2.1 Takeda Pharmaceuticals Company Information
11.2.2 Takeda Pharmaceuticals Overview
11.2.3 Takeda Pharmaceuticals Antidiabetics Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Takeda Pharmaceuticals Antidiabetics Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Takeda Pharmaceuticals Recent Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Company Information
11.3.2 Eli Lilly Overview
11.3.3 Eli Lilly Antidiabetics Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Eli Lilly Antidiabetics Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Eli Lilly Recent Developments
11.4 Oramed Pharmaceuticals
11.4.1 Oramed Pharmaceuticals Company Information
11.4.2 Oramed Pharmaceuticals Overview
11.4.3 Oramed Pharmaceuticals Antidiabetics Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Oramed Pharmaceuticals Antidiabetics Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Oramed Pharmaceuticals Recent Developments
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Information
11.5.2 Boehringer Ingelheim Overview
11.5.3 Boehringer Ingelheim Antidiabetics Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Boehringer Ingelheim Antidiabetics Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Boehringer Ingelheim Recent Developments
11.6 Merck & Co. Inc.
11.6.1 Merck & Co. Inc. Company Information
11.6.2 Merck & Co. Inc. Overview
11.6.3 Merck & Co. Inc. Antidiabetics Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Merck & Co. Inc. Antidiabetics Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Merck & Co. Inc. Recent Developments
11.7 Novo Nordisk
11.7.1 Novo Nordisk Company Information
11.7.2 Novo Nordisk Overview
11.7.3 Novo Nordisk Antidiabetics Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Novo Nordisk Antidiabetics Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Novo Nordisk Recent Developments
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Information
11.8.2 Bristol-Myers Squibb Overview
11.8.3 Bristol-Myers Squibb Antidiabetics Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Bristol-Myers Squibb Antidiabetics Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bristol-Myers Squibb Recent Developments
11.9 Halozyme Therapeutics
11.9.1 Halozyme Therapeutics Company Information
11.9.2 Halozyme Therapeutics Overview
11.9.3 Halozyme Therapeutics Antidiabetics Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Halozyme Therapeutics Antidiabetics Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Halozyme Therapeutics Recent Developments
11.10 Pfizer
11.10.1 Pfizer Company Information
11.10.2 Pfizer Overview
11.10.3 Pfizer Antidiabetics Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Pfizer Antidiabetics Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Pfizer Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Antidiabetics Industry Chain Analysis
12.2 Antidiabetics Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Antidiabetics Production Mode & Process
12.4 Antidiabetics Sales and Marketing
12.4.1 Antidiabetics Sales Channels
12.4.2 Antidiabetics Distributors
12.5 Antidiabetics Customers
13 Market Dynamics
13.1 Antidiabetics Industry Trends
13.2 Antidiabetics Market Drivers
13.3 Antidiabetics Market Challenges
13.4 Antidiabetics Market Restraints
14 Key Findings in The Global Antidiabetics Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Antidiabetics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Type 1 Diabetes
Table 3. Major Manufacturers of Type 2 Diabetes
Table 4. Major Manufacturers of Other
Table 5. Global Antidiabetics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Antidiabetics Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Antidiabetics Revenue by Region (2018-2023) & (US$ Million)
Table 8. Global Antidiabetics Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global Antidiabetics Revenue Market Share by Region (2018-2023)
Table 10. Global Antidiabetics Revenue Market Share by Region (2024-2029)
Table 11. Global Antidiabetics Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Antidiabetics Sales by Region (2018-2023) & (K Units)
Table 13. Global Antidiabetics Sales by Region (2024-2029) & (K Units)
Table 14. Global Antidiabetics Sales Market Share by Region (2018-2023)
Table 15. Global Antidiabetics Sales Market Share by Region (2024-2029)
Table 16. Global Antidiabetics Sales by Manufacturers (2018-2023) & (K Units)
Table 17. Global Antidiabetics Sales Share by Manufacturers (2018-2023)
Table 18. Global Antidiabetics Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 19. Global Antidiabetics Revenue Share by Manufacturers (2018-2023)
Table 20. Global Key Players of Antidiabetics, Industry Ranking, 2021 VS 2022 VS 2023
Table 21. Antidiabetics Price by Manufacturers 2018-2023 (USD/Unit)
Table 22. Global Antidiabetics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Antidiabetics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antidiabetics as of 2022)
Table 24. Global Key Manufacturers of Antidiabetics, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Antidiabetics, Product Offered and Application
Table 26. Global Key Manufacturers of Antidiabetics, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Antidiabetics Sales by Type (2018-2023) & (K Units)
Table 29. Global Antidiabetics Sales by Type (2024-2029) & (K Units)
Table 30. Global Antidiabetics Sales Share by Type (2018-2023)
Table 31. Global Antidiabetics Sales Share by Type (2024-2029)
Table 32. Global Antidiabetics Revenue by Type (2018-2023) & (US$ Million)
Table 33. Global Antidiabetics Revenue by Type (2024-2029) & (US$ Million)
Table 34. Global Antidiabetics Revenue Share by Type (2018-2023)
Table 35. Global Antidiabetics Revenue Share by Type (2024-2029)
Table 36. Antidiabetics Price by Type (2018-2023) & (USD/Unit)
Table 37. Global Antidiabetics Price Forecast by Type (2024-2029) & (USD/Unit)
Table 38. Global Antidiabetics Sales by Application (2018-2023) & (K Units)
Table 39. Global Antidiabetics Sales by Application (2024-2029) & (K Units)
Table 40. Global Antidiabetics Sales Share by Application (2018-2023)
Table 41. Global Antidiabetics Sales Share by Application (2024-2029)
Table 42. Global Antidiabetics Revenue by Application (2018-2023) & (US$ Million)
Table 43. Global Antidiabetics Revenue by Application (2024-2029) & (US$ Million)
Table 44. Global Antidiabetics Revenue Share by Application (2018-2023)
Table 45. Global Antidiabetics Revenue Share by Application (2024-2029)
Table 46. Antidiabetics Price by Application (2018-2023) & (USD/Unit)
Table 47. Global Antidiabetics Price Forecast by Application (2024-2029) & (USD/Unit)
Table 48. US & Canada Antidiabetics Sales by Type (2018-2023) & (K Units)
Table 49. US & Canada Antidiabetics Sales by Type (2024-2029) & (K Units)
Table 50. US & Canada Antidiabetics Revenue by Type (2018-2023) & (US$ Million)
Table 51. US & Canada Antidiabetics Revenue by Type (2024-2029) & (US$ Million)
Table 52. US & Canada Antidiabetics Sales by Application (2018-2023) & (K Units)
Table 53. US & Canada Antidiabetics Sales by Application (2024-2029) & (K Units)
Table 54. US & Canada Antidiabetics Revenue by Application (2018-2023) & (US$ Million)
Table 55. US & Canada Antidiabetics Revenue by Application (2024-2029) & (US$ Million)
Table 56. US & Canada Antidiabetics Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 57. US & Canada Antidiabetics Revenue by Country (2018-2023) & (US$ Million)
Table 58. US & Canada Antidiabetics Revenue by Country (2024-2029) & (US$ Million)
Table 59. US & Canada Antidiabetics Sales by Country (2018-2023) & (K Units)
Table 60. US & Canada Antidiabetics Sales by Country (2024-2029) & (K Units)
Table 61. Europe Antidiabetics Sales by Type (2018-2023) & (K Units)
Table 62. Europe Antidiabetics Sales by Type (2024-2029) & (K Units)
Table 63. Europe Antidiabetics Revenue by Type (2018-2023) & (US$ Million)
Table 64. Europe Antidiabetics Revenue by Type (2024-2029) & (US$ Million)
Table 65. Europe Antidiabetics Sales by Application (2018-2023) & (K Units)
Table 66. Europe Antidiabetics Sales by Application (2024-2029) & (K Units)
Table 67. Europe Antidiabetics Revenue by Application (2018-2023) & (US$ Million)
Table 68. Europe Antidiabetics Revenue by Application (2024-2029) & (US$ Million)
Table 69. Europe Antidiabetics Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 70. Europe Antidiabetics Revenue by Country (2018-2023) & (US$ Million)
Table 71. Europe Antidiabetics Revenue by Country (2024-2029) & (US$ Million)
Table 72. Europe Antidiabetics Sales by Country (2018-2023) & (K Units)
Table 73. Europe Antidiabetics Sales by Country (2024-2029) & (K Units)
Table 74. China Antidiabetics Sales by Type (2018-2023) & (K Units)
Table 75. China Antidiabetics Sales by Type (2024-2029) & (K Units)
Table 76. China Antidiabetics Revenue by Type (2018-2023) & (US$ Million)
Table 77. China Antidiabetics Revenue by Type (2024-2029) & (US$ Million)
Table 78. China Antidiabetics Sales by Application (2018-2023) & (K Units)
Table 79. China Antidiabetics Sales by Application (2024-2029) & (K Units)
Table 80. China Antidiabetics Revenue by Application (2018-2023) & (US$ Million)
Table 81. China Antidiabetics Revenue by Application (2024-2029) & (US$ Million)
Table 82. Asia Antidiabetics Sales by Type (2018-2023) & (K Units)
Table 83. Asia Antidiabetics Sales by Type (2024-2029) & (K Units)
Table 84. Asia Antidiabetics Revenue by Type (2018-2023) & (US$ Million)
Table 85. Asia Antidiabetics Revenue by Type (2024-2029) & (US$ Million)
Table 86. Asia Antidiabetics Sales by Application (2018-2023) & (K Units)
Table 87. Asia Antidiabetics Sales by Application (2024-2029) & (K Units)
Table 88. Asia Antidiabetics Revenue by Application (2018-2023) & (US$ Million)
Table 89. Asia Antidiabetics Revenue by Application (2024-2029) & (US$ Million)
Table 90. Asia Antidiabetics Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Antidiabetics Revenue by Region (2018-2023) & (US$ Million)
Table 92. Asia Antidiabetics Revenue by Region (2024-2029) & (US$ Million)
Table 93. Asia Antidiabetics Sales by Region (2018-2023) & (K Units)
Table 94. Asia Antidiabetics Sales by Region (2024-2029) & (K Units)
Table 95. Middle East, Africa and Latin America Antidiabetics Sales by Type (2018-2023) & (K Units)
Table 96. Middle East, Africa and Latin America Antidiabetics Sales by Type (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America Antidiabetics Revenue by Type (2018-2023) & (US$ Million)
Table 98. Middle East, Africa and Latin America Antidiabetics Revenue by Type (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America Antidiabetics Sales by Application (2018-2023) & (K Units)
Table 100. Middle East, Africa and Latin America Antidiabetics Sales by Application (2024-2029) & (K Units)
Table 101. Middle East, Africa and Latin America Antidiabetics Revenue by Application (2018-2023) & (US$ Million)
Table 102. Middle East, Africa and Latin America Antidiabetics Revenue by Application (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Antidiabetics Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 104. Middle East, Africa and Latin America Antidiabetics Revenue by Country (2018-2023) & (US$ Million)
Table 105. Middle East, Africa and Latin America Antidiabetics Revenue by Country (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Antidiabetics Sales by Country (2018-2023) & (K Units)
Table 107. Middle East, Africa and Latin America Antidiabetics Sales by Country (2024-2029) & (K Units)
Table 108. Sanofi-Aventis Company Information
Table 109. Sanofi-Aventis Description and Major Businesses
Table 110. Sanofi-Aventis Antidiabetics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 111. Sanofi-Aventis Antidiabetics Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Sanofi-Aventis Recent Developments
Table 113. Takeda Pharmaceuticals Company Information
Table 114. Takeda Pharmaceuticals Description and Major Businesses
Table 115. Takeda Pharmaceuticals Antidiabetics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 116. Takeda Pharmaceuticals Antidiabetics Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Takeda Pharmaceuticals Recent Developments
Table 118. Eli Lilly Company Information
Table 119. Eli Lilly Description and Major Businesses
Table 120. Eli Lilly Antidiabetics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 121. Eli Lilly Antidiabetics Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Eli Lilly Recent Developments
Table 123. Oramed Pharmaceuticals Company Information
Table 124. Oramed Pharmaceuticals Description and Major Businesses
Table 125. Oramed Pharmaceuticals Antidiabetics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 126. Oramed Pharmaceuticals Antidiabetics Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Oramed Pharmaceuticals Recent Developments
Table 128. Boehringer Ingelheim Company Information
Table 129. Boehringer Ingelheim Description and Major Businesses
Table 130. Boehringer Ingelheim Antidiabetics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 131. Boehringer Ingelheim Antidiabetics Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Boehringer Ingelheim Recent Developments
Table 133. Merck & Co. Inc. Company Information
Table 134. Merck & Co. Inc. Description and Major Businesses
Table 135. Merck & Co. Inc. Antidiabetics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 136. Merck & Co. Inc. Antidiabetics Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Merck & Co. Inc. Recent Developments
Table 138. Novo Nordisk Company Information
Table 139. Novo Nordisk Description and Major Businesses
Table 140. Novo Nordisk Antidiabetics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 141. Novo Nordisk Antidiabetics Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Novo Nordisk Recent Developments
Table 143. Bristol-Myers Squibb Company Information
Table 144. Bristol-Myers Squibb Description and Major Businesses
Table 145. Bristol-Myers Squibb Antidiabetics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 146. Bristol-Myers Squibb Antidiabetics Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Bristol-Myers Squibb Recent Developments
Table 148. Halozyme Therapeutics Company Information
Table 149. Halozyme Therapeutics Description and Major Businesses
Table 150. Halozyme Therapeutics Antidiabetics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 151. Halozyme Therapeutics Antidiabetics Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Halozyme Therapeutics Recent Developments
Table 153. Pfizer Company Information
Table 154. Pfizer Description and Major Businesses
Table 155. Pfizer Antidiabetics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 156. Pfizer Antidiabetics Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Pfizer Recent Developments
Table 158. Key Raw Materials Lists
Table 159. Raw Materials Key Suppliers Lists
Table 160. Antidiabetics Distributors List
Table 161. Antidiabetics Customers List
Table 162. Antidiabetics Market Trends
Table 163. Antidiabetics Market Drivers
Table 164. Antidiabetics Market Challenges
Table 165. Antidiabetics Market Restraints
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Antidiabetics Product Picture
Figure 2. Global Antidiabetics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Antidiabetics Market Share by Type in 2022 & 2029
Figure 4. Type 1 Diabetes Product Picture
Figure 5. Type 2 Diabetes Product Picture
Figure 6. Other Product Picture
Figure 7. Global Antidiabetics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Antidiabetics Market Share by Application in 2022 & 2029
Figure 9. Hospital Use
Figure 10. Clinic Use
Figure 11. Household
Figure 12. Other
Figure 13. Antidiabetics Report Years Considered
Figure 14. Global Antidiabetics Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Antidiabetics Revenue 2018-2029 (US$ Million)
Figure 16. Global Antidiabetics Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 17. Global Antidiabetics Revenue Market Share by Region (2018-2029)
Figure 18. Global Antidiabetics Sales 2018-2029 ((K Units)
Figure 19. Global Antidiabetics Sales Market Share by Region (2018-2029)
Figure 20. US & Canada Antidiabetics Sales YoY (2018-2029) & (K Units)
Figure 21. US & Canada Antidiabetics Revenue YoY (2018-2029) & (US$ Million)
Figure 22. Europe Antidiabetics Sales YoY (2018-2029) & (K Units)
Figure 23. Europe Antidiabetics Revenue YoY (2018-2029) & (US$ Million)
Figure 24. China Antidiabetics Sales YoY (2018-2029) & (K Units)
Figure 25. China Antidiabetics Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Asia (excluding China) Antidiabetics Sales YoY (2018-2029) & (K Units)
Figure 27. Asia (excluding China) Antidiabetics Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Antidiabetics Sales YoY (2018-2029) & (K Units)
Figure 29. Middle East, Africa and Latin America Antidiabetics Revenue YoY (2018-2029) & (US$ Million)
Figure 30. The Antidiabetics Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 31. The Top 5 and 10 Largest Manufacturers of Antidiabetics in the World: Market Share by Antidiabetics Revenue in 2022
Figure 32. Global Antidiabetics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Antidiabetics Sales Market Share by Type (2018-2029)
Figure 34. Global Antidiabetics Revenue Market Share by Type (2018-2029)
Figure 35. Global Antidiabetics Sales Market Share by Application (2018-2029)
Figure 36. Global Antidiabetics Revenue Market Share by Application (2018-2029)
Figure 37. US & Canada Antidiabetics Sales Market Share by Type (2018-2029)
Figure 38. US & Canada Antidiabetics Revenue Market Share by Type (2018-2029)
Figure 39. US & Canada Antidiabetics Sales Market Share by Application (2018-2029)
Figure 40. US & Canada Antidiabetics Revenue Market Share by Application (2018-2029)
Figure 41. US & Canada Antidiabetics Revenue Share by Country (2018-2029)
Figure 42. US & Canada Antidiabetics Sales Share by Country (2018-2029)
Figure 43. U.S. Antidiabetics Revenue (2018-2029) & (US$ Million)
Figure 44. Canada Antidiabetics Revenue (2018-2029) & (US$ Million)
Figure 45. Europe Antidiabetics Sales Market Share by Type (2018-2029)
Figure 46. Europe Antidiabetics Revenue Market Share by Type (2018-2029)
Figure 47. Europe Antidiabetics Sales Market Share by Application (2018-2029)
Figure 48. Europe Antidiabetics Revenue Market Share by Application (2018-2029)
Figure 49. Europe Antidiabetics Revenue Share by Country (2018-2029)
Figure 50. Europe Antidiabetics Sales Share by Country (2018-2029)
Figure 51. Germany Antidiabetics Revenue (2018-2029) & (US$ Million)
Figure 52. France Antidiabetics Revenue (2018-2029) & (US$ Million)
Figure 53. U.K. Antidiabetics Revenue (2018-2029) & (US$ Million)
Figure 54. Italy Antidiabetics Revenue (2018-2029) & (US$ Million)
Figure 55. Russia Antidiabetics Revenue (2018-2029) & (US$ Million)
Figure 56. China Antidiabetics Sales Market Share by Type (2018-2029)
Figure 57. China Antidiabetics Revenue Market Share by Type (2018-2029)
Figure 58. China Antidiabetics Sales Market Share by Application (2018-2029)
Figure 59. China Antidiabetics Revenue Market Share by Application (2018-2029)
Figure 60. Asia Antidiabetics Sales Market Share by Type (2018-2029)
Figure 61. Asia Antidiabetics Revenue Market Share by Type (2018-2029)
Figure 62. Asia Antidiabetics Sales Market Share by Application (2018-2029)
Figure 63. Asia Antidiabetics Revenue Market Share by Application (2018-2029)
Figure 64. Asia Antidiabetics Revenue Share by Region (2018-2029)
Figure 65. Asia Antidiabetics Sales Share by Region (2018-2029)
Figure 66. Japan Antidiabetics Revenue (2018-2029) & (US$ Million)
Figure 67. South Korea Antidiabetics Revenue (2018-2029) & (US$ Million)
Figure 68. China Taiwan Antidiabetics Revenue (2018-2029) & (US$ Million)
Figure 69. Southeast Asia Antidiabetics Revenue (2018-2029) & (US$ Million)
Figure 70. India Antidiabetics Revenue (2018-2029) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Antidiabetics Sales Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Antidiabetics Revenue Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Antidiabetics Sales Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Antidiabetics Revenue Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Antidiabetics Revenue Share by Country (2018-2029)
Figure 76. Middle East, Africa and Latin America Antidiabetics Sales Share by Country (2018-2029)
Figure 77. Brazil Antidiabeti
  • Global Metformin Hydrochloride Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104
    Metformin hydrochloride is The raw material of finished product metformin hydrochloride drugs. That is The API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in The management of type 2-diabetes. Metformin hydrochloride (N, N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents. Metformin hydrochloride is a white to off-white crystall......
  • Global Antidiabetic Sulphonylureas Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Antidiabetic Sulphonylureas market: According to our latest research, the global Antidiabetic Sulphonylureas market looks promising in the next 5 years. As of 2022, the global Antidiabetic Sulphonylureas market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of t......
  • Global Insulin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101
    According to our LPI (LP Information) latest study, the global Insulin market size was valued at US$ million in 2023. With growing demand in downstream market, the Insulin is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Insulin market. Insulin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization......
  • Global Insulin API Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116
    According to our LPI (LP Information) latest study, the global Insulin API market size was valued at US$ 1707.6 million in 2023. With growing demand in downstream market, the Insulin API is forecast to a readjusted size of US$ 2101.4 million by 2030 with a CAGR of 3.0% during review period. The research report highlights the growth potential of the global Insulin API market. Insulin API are expected to show stable growth in the future market. However, product differentiation, reducing co......
  • Global Glucagon Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101
    According to our LPI (LP Information) latest study, the global Glucagon market size was valued at US$ 543.9 million in 2023. With growing demand in downstream market, the Glucagon is forecast to a readjusted size of US$ 835.7 million by 2030 with a CAGR of 6.3% during review period. The research report highlights the growth potential of the global Glucagon market. Glucagon are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
  • Global Acarbose Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Acarbose market size was valued at US$ 135.8 million in 2023. With growing demand in downstream market, the Acarbose is forecast to a readjusted size of US$ 165.9 million by 2030 with a CAGR of 2.9% during review period. The research report highlights the growth potential of the global Acarbose market. Acarbose are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
  • Global Insulin Glargine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 77
    According to our LPI (LP Information) latest study, the global Insulin Glargine market size was valued at US$ 6562.1 million in 2023. With growing demand in downstream market, the Insulin Glargine is forecast to a readjusted size of US$ 8722.5 million by 2030 with a CAGR of 4.1% during review period. The research report highlights the growth potential of the global Insulin Glargine market. Insulin Glargine are expected to show stable growth in the future market. However, product differen......
  • Global Liraglutide Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 103
    According to our LPI (LP Information) latest study, the global Liraglutide market size was valued at US$ million in 2023. With growing demand in downstream market, the Liraglutide is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Liraglutide market. Liraglutide are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ch......
  • Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global Glucagon Like Peptide-1 (GLP-1) Agonists market size was valued at US$ 8624.4 million in 2023. With growing demand in downstream market, the Glucagon Like Peptide-1 (GLP-1) Agonists is forecast to a readjusted size of US$ 21310 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Glucagon Like Peptide-1 (GLP-1) Agonists market. Glucagon Like Peptide-1 (GL......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs